These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17201699

  • 1. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
    Koenig SA, Buesing D, Longin E, Oehring R, Häussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H, Samii K, Jungck A, Brückner R, Seitz R, Boxtermann W, Weber Y, Knapp R, Richard HH, Weidner B, Kasper JM, Haensch CA, Fitzek S, Hartmann M, Borusiak P, Müller-Deile A, Degenhardt V, Korenke GC, Hoppen T, Specht U, Gerstner T.
    Epilepsia; 2006 Dec; 47(12):2027-31. PubMed ID: 17201699
    [Abstract] [Full Text] [Related]

  • 2. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.
    König SA, Siemes H, Bläker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Köhler B, Koelfen W, Korinthenberg R.
    Epilepsia; 1994 Dec; 35(5):1005-15. PubMed ID: 7925143
    [Abstract] [Full Text] [Related]

  • 3. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S, Farrell K, Abbott F.
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM.
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [Abstract] [Full Text] [Related]

  • 9. [Hepatotoxicity induced by valproic acid in adults. Report of 3 cases].
    Galdames D, Silva C, Aguilera L, Chesta J.
    Rev Med Chil; 1993 Dec; 121(12):1432-6. PubMed ID: 8085069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T, Treiss I, Kohlmueller D, Mehlem P, Teich M, Longin E, Gerstner T, Koenig SA, Schulze A.
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [Abstract] [Full Text] [Related]

  • 13. Valproic acid hepatic fatalities: a retrospective review.
    Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB.
    Neurology; 1987 Mar; 37(3):379-85. PubMed ID: 3102998
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses].
    Ghozzi H, Hakim A, Sahnoun Z, Ben Mahmoud L, Atheymen R, Hammami S, Zeghal K.
    Rev Neurol (Paris); 2011 Mar; 167(8-9):600-6. PubMed ID: 21492891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fatal liver failure in 16 children with valproate therapy.
    Scheffner D, König S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S.
    Epilepsia; 1988 Mar; 29(5):530-42. PubMed ID: 3137017
    [Abstract] [Full Text] [Related]

  • 19. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S, Seo T, Hagiwara T, Ueda K, Yamauchi T, Nagata S, Ando Y, Ishitsu T, Nakagawa K.
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.